APA

Greven D. E. A., Cohen E. S., Gerlag D. M., Campbell J., Woods J., Davis N., van Nieuwenhuijze A., Lewis A., Heasmen S., McCourt M., Corkill D., Dodd A., Elvin J., Statache G., Wicks I. P., Anderson I. K., Nash A., Sleeman M. A. & Tak P. P. (20151202). Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. : Annals of the rheumatic diseases.

Chicago

Greven D E A, Cohen E S, Gerlag D M, Campbell J, Woods J, Davis N, van Nieuwenhuijze A, Lewis A, Heasmen S, McCourt M, Corkill D, Dodd A, Elvin J, Statache G, Wicks I P, Anderson I K, Nash A, Sleeman M A and Tak P P. 20151202. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. : Annals of the rheumatic diseases.

Harvard

Greven D. E. A., Cohen E. S., Gerlag D. M., Campbell J., Woods J., Davis N., van Nieuwenhuijze A., Lewis A., Heasmen S., McCourt M., Corkill D., Dodd A., Elvin J., Statache G., Wicks I. P., Anderson I. K., Nash A., Sleeman M. A. and Tak P. P. (20151202). Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. : Annals of the rheumatic diseases.

MLA

Greven D E A, Cohen E S, Gerlag D M, Campbell J, Woods J, Davis N, van Nieuwenhuijze A, Lewis A, Heasmen S, McCourt M, Corkill D, Dodd A, Elvin J, Statache G, Wicks I P, Anderson I K, Nash A, Sleeman M A and Tak P P. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. : Annals of the rheumatic diseases. 20151202.